{
    "title": "Gilead raises sales outlook to include COVID-19 treatment remdesivir",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8578167/Gilead-posts-weaker-expected-quarterly-results-sales-lag-pandemic.html",
    "date": "2020-07-30",
    "keywords": [
        "drug",
        "remdesivir",
        "year",
        "company",
        "gilead",
        "beasley",
        "michael",
        "revenue",
        "analyst",
        "estimate",
        "hiv",
        "hepatitis",
        "quarter",
        "trading",
        "month",
        "demand",
        "trial",
        "thursday",
        "range",
        "start",
        "flagship",
        "momentum",
        "share",
        "secondquarter",
        "c",
        "competition",
        "infusion",
        "emergency",
        "use",
        "authorization",
        "food",
        "administration",
        "ability",
        "covid19",
        "approval",
        "supply",
        "world",
        "executive",
        "daniel",
        "oday",
        "conference",
        "call",
        "end",
        "september",
        "manufacturer",
        "treatment",
        "outlook",
        "formulation",
        "aim",
        "tissue",
        "earlierstage",
        "institute",
        "allergy",
        "combination",
        "co",
        "steroid",
        "dexamethasone",
        "reporting",
        "deena",
        "bill",
        "berkrot",
        "leslie",
        "adler"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}